SERUM ERYTHROPOIETIN CONCENTRATIONS AND IRON STATUS IN PATIENTS ON CHRONIC-HEMODIALYSIS

被引:0
|
作者
SEGUCHI, C
SHIMA, T
MISAKI, M
TAKARADA, Y
OKAZAKI, T
机构
[1] MIE UNIV,SCH MED,DEPT INTERNAL MED 3,TSU,MIE 514,JAPAN
[2] MIE UNIV,CTR STUDENT HLTH,TSU,MIE 514,JAPAN
[3] NATL TSU HOSP,HISAI,MIE 51411,JAPAN
关键词
IRON-BINDING CAPACITY; FERRITIN; ANEMIA; RADIOIMMUNOASSAY; CHRONIC RENAL FAILURE;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We studied the relationship between serum erythropoietin (EPO) concentration and iron status in 67 patients undergoing chronic hemodialysis. Serum concentrations of EPO were measured by RIA with recombinant human EPO. The geometric mean of the serum EPO concentration was 10.9 int. units/L (mean +/- SD range = 7.8 - 15.3 int. units/L) in hemodialysis patients, considerably lower than that in normal subjects (12.9 int. units/L). We found no significant correlation between concentrations of serum EPO and hemoglobin in hemodialysis patients, but found a significant negative correlation between serum concentrations of EPO and iron in hemodialysis patients. Moreover, we also found a significant positive correlation between the EPO concentration and the unsaturated iron-binding capacity (UIBC) in serum, and a significant negative correlation between the serum concentrations of EPO and ferritin in hemodialysis patients. Several patients who had relatively high EPO concentrations for hemodialysis patients also had low iron concentrations, high UIBC values, and low ferritin concentrations. These findings suggest that iron was utilized even at these EPO concentrations, which were very low for the degree of anemia observed in the hemodialysis patients.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 50 条
  • [21] RECOMBINANT ERYTHROPOIETIN IMPROVES COGNITIVE FUNCTION IN CHRONIC-HEMODIALYSIS PATIENTS
    TEMPLE, RM
    LANGAN, SJ
    DEARY, IJ
    WINNEY, RJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (03) : 240 - 245
  • [22] WEEKLY SUBCUTANEOUS ERYTHROPOIETIN MAINTAINS HEMATOCRIT IN CHRONIC-HEMODIALYSIS PATIENTS
    PARKER, KP
    SANDS, JM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1993, 3 (10): : 1717 - 1718
  • [23] THE ERYTHROPOIETIN DOSE CORRELATES WITH DIALYSIS ADEQUACY IN PATIENTS ON CHRONIC-HEMODIALYSIS
    STEGEMAN, CA
    KLOPPENBURG, WD
    HUISMAN, RM
    DEJONG, PE
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 563 - 563
  • [24] ERYTHROPOIETIN AND IMPROVEMENT IN THE ERYTHROPOIESIS OF CHRONIC-HEMODIALYSIS PATIENTS TREATED WITH DESFERRIOXAMINE
    DELASERNA, FJ
    GILSANZ, F
    PRAGA, M
    ESTENOZ, J
    CLINICAL NEPHROLOGY, 1991, 36 (03) : 157 - 158
  • [25] IS FOLATE SUPPLEMENTATION NECESSARY IN CHRONIC-HEMODIALYSIS PATIENTS THAT ARE TREATED WITH ERYTHROPOIETIN
    DUCLOS, J
    SIEBERTH, HG
    MANN, H
    REVISTA MEDICA DE CHILE, 1993, 121 (01) : 30 - 35
  • [26] HEMOSTATIC EFFECTS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN CHRONIC-HEMODIALYSIS PATIENTS
    VANGEET, C
    HAUGLUSTAINE, D
    VERRESEN, L
    VANRUSSELT, M
    VERMYLEN, J
    THROMBOSIS AND HAEMOSTASIS, 1989, 61 (01) : 117 - 121
  • [27] LOW-DOSE HUMAN ERYTHROPOIETIN IN CHRONIC-HEMODIALYSIS PATIENTS
    SOLOZABAL, C
    MADUELL, F
    UNZUE, J
    ASIN, JL
    NEPHRON, 1991, 57 (04): : 483 - 484
  • [28] HUMAN RECOMBINANT ERYTHROPOIETIN EFFECTS ON ANEMIA IN CHRONIC-HEMODIALYSIS PATIENTS
    CASATI, S
    PASSERINI, P
    GRAZIANI, G
    PONTICELLI, C
    KIDNEY INTERNATIONAL, 1988, 33 (02) : 623 - 623
  • [29] WEEKLY SUBCUTANEOUS ERYTHROPOIETIN MAINTAINS HEMATOCRIT IN CHRONIC-HEMODIALYSIS PATIENTS
    PARKER, KP
    LACOURSIERE, T
    MACON, EJ
    STIVELMAN, JC
    BAILEY, JL
    KIKERI, D
    MITCH, WE
    SANDS, JM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 470 - 470
  • [30] INFLUENCE OF ERYTHROPOIETIN ON TRACE-ELEMENTS IN CHRONIC-HEMODIALYSIS PATIENTS
    HOSOKAWA, S
    YOSHIDA, O
    ADVANCES IN THERAPY, 1992, 9 (05) : 302 - 309